Korean doctors’ prescription rate of antibiotics to treat colds plunged to 35 percent in 2021 from 73 percent in 2002, according to a report released Friday by the Health Insurance Review and Assessment Service (HIRA).Tertiary general hospitals’ antibiotics prescription rate for a cold remained at a
Cancer is thought to be synonymous with death and suffering. Therefore, it is easy to find cancer patients among our family and friends.According to the 2019 national cancer registration statistics in Korea, 1 out of 25 people (a total patient population of 2,147,503 people) are either receiving can
As drinkable liquid formulation dementia treatments have won domestic approval, attention is drawn to what effects they will have on the market, industry insiders said Thursday.The Ministry of Food and Drug Safety recently approved Genuone Sciences’ Keicept 5 mg (ingredient: donepezil hydrochloride)
The U.S. Food and Drug Administration has approved the application to expand indications for Enhertu (ingredient: trastuzumab deruxtecan) submitted by Daiichi Sankyo and AstraZeneca, industry sources said Thursday.That means the FDA will decide whether to permit its use for HER2-low metastatic breas
A renowned epidemiological expert said Thursday that the peak of the Covid-19 resurgence might come earlier than expected, but the maximum daily tally would be lower than the estimation in the original worst-case scenario."Based on various shreds of evidence, I think the country will not see a daily
Samsung Biologics said Wednesday it surpassed 1 trillion won in sales ($768 million) in the first half-year for the first time since its foundation, thanks to the rapid growth of its contract manufacturing organization business.In the second quarter, the company recorded 651.4 billion in sales and 1
Astellas Korea said Wednesday that its prostate cancer treatment, Xtandi, (ingredient name: enzalutamide), will be covered by selective benefits in treating hormone-responsive metastatic prostate cancer (mHSPC) combined with androgen deprivation therapy (ADT).Xtandi is a prostate cancer treatment wi
ISU Abxis said Wednesday that it signed a contract to supply up to 14 billion won ($10.7 million) of gaucher disease treatment, Abcertin, with Algeria’s Pharmacy Central Hospital (PCH).PCH is an institution that exclusively procures medicines and medical supplies for all public hospitals in Algeria.
Jeil Pharmaceutical announced on Thursday that it has signed a domestic exclusive supply contract of cefiderocol, a super-antibiotics of Ping An-Shionogi based on the siderophore cephalosporin antibiotic component.Ping An-Shionogi, a joint corporation of Japan’s Shionogi and Hong Kong’s Ping An, has
The government is stepping up efforts to develop the biopharmaceutical sector into the country's next growth engine with various support plans, ranging from tax reduction to clinical trial support.For starters, it will provide Korean companies that purchase overseas vaccine technology companies with
Korea’s daily Covid-19 cases bounced back above 100,000 on Wednesday, as the BA.5, an Omicron subvariant, has emerged as the dominant strain.The Korea Disease Control and Prevention Agency (KDCA) confirmed 100,285 new virus cases, raising the cumulative caseload to 19,446,946. Wednesday's number is
The Korea Advanced Institute of Science and Technology (KAIST) said its research team, alongside several university hospitals, has jointly developed a self-evolutionary artificial intelligence (AI) algorithm to improve the automated reading of X-ray images .In collaboration with Seoul National Unive
Compared to other OECD member nations, Koreans use more health and medical services, and the nation has more medical equipment but fewer health workers, such as doctors and nurses.The Ministry of Health and Welfare released its analysis of Korea’s health and medical indicators in the “OECD Health St
Daesang Life Science said it signed a letter of intent (LOI) with Sinopharm International on Tuesday to establish a joint manufacturing and sales corporation for health foods in China’s Hainan Province.Under the accord, Daesang and Sinopharm International will collaborate on the health industry base
A study has found that breast cancer surgery using robots reduces complications and preserves the shape of the breast as much as possible.Two researchers -- Professor Park Hyung-seok of Yonsei Cancer Center and Professor Lee Jee-a at Eulji Medical Center’s Breast Clinic – discovered that robotic sur
Hanmi Pharmaceutical said it has completed preparations for product release, as it has become the first Korean company to win all four patent suits concerning the use patent of Entresto, Novartis’ chronic heart failure treatment.Hanmi, also the first in Korea to meet requirements for priority sales
The Joint Committee with Migrants in Korea (JCMK) on Tuesday called for beginning discussion in earnest on legalizing unregistered migrant workers in response to the Covid-19 resurgence and labor shortage.In a statement, the committee cited the parliamentary interpellation session on Monday, in whic
What would it be if we had to pick one piece of information most important for the genetic diagnosis of rare disease patients?The information required for genetic diagnosis is very diverse, such as the correlation between genes and diseases, the function of genes, important location information that
The stock prices of Korean pharmaceutical companies developing Alzheimer's disease treatment dropped as suspicions arose about the possible manipulation of a research paper on amyloid beta, a key substance in dementia treatment.Cellivery Therapeutics, a company developing iCP-Parkin, a Parkinson's d
Hugel’s botulinus toxin medication, Botulax (Letybo), has proved to be effective in improving furrows between eyebrows through phase 3 clinical trials in the U.S. and Europe, the company said Tuesday.It added that the trial results were published in the June issue of Aesthetic Surgery Journal.Accord